![](https://geistlich.us/wp-content/uploads/clinical-case-bg.jpg)
CLINICAL CASE
![](https://geistlich.us/wp-content/uploads/2-urban_1.jpg)
![](https://geistlich.us/wp-content/uploads/2-urban_2.jpg)
![](https://geistlich.us/wp-content/uploads/2-urban_3.jpg)
![](https://geistlich.us/wp-content/uploads/2-urban_4.jpg)
![](https://geistlich.us/wp-content/uploads/2-urban_5.jpg)
![](https://geistlich.us/wp-content/uploads/2-urban_6.jpg)
![](https://geistlich.us/wp-content/uploads/2-urban_7.jpg)
![](https://geistlich.us/wp-content/uploads/2-urban_8.jpg)
![](https://geistlich.us/wp-content/uploads/2-urban_9.jpg)
![](https://geistlich.us/wp-content/uploads/2-urban_10.jpg)
![](https://geistlich.us/wp-content/uploads/2-urban_11.jpg)
![](https://geistlich.us/wp-content/uploads/2-urban_12.jpg)
Download our new eBook and learn how to 4C predictability
GEM 21S®, the first recombinant growth factor product for use in oral regenerative surgery. Learn More
Geistlich unveils vallos®, a full line of allograft granules and fibers. Discover vallos®